Table 4.
Parameter | sHR (95% CI) | p value |
---|---|---|
Nosocomial infection (yes vs no) | 6.80 (3.06–15.13) | ≪0.001 |
MELD score (1-point increase) | 1.13 (1.08–1.18) | ≪0.001 |
Hemoglobin (1 g/dl increase) | 0.82 (0.69–0.99) | 0.040 |
Leukocyte (109/L increase) | 1.12 (1.07–1.17) | ≪0.001 |
In-hospital mortality, liver transplantation and hospital discharge were considered as competing events. Data are presented as sub-distribution hazard ratio and 95% confidence interval. Variable entered in the first step included also ascites, serum albumin, C-reactive protein and heart rate at hospital admission. The disease severity score to be included in the analysis was selected by the receiver-operating characteristic analysis.
ACLF, acute-on-chronic liver failure; CRR, competing risk regression; MELD, model for end-stage liver disease.